VAIDYA SANE AYURVED LABORATORIES LTD (MADHAVBAUG) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by VAIDYA SANE AYURVED LABORATORIES LTD on NSE and BSE, with an AI summary of each filing.
VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
Vaidya Sane Ayurved Laboratories Schedules Board Meeting on 5th Nov'26 for Half-Yearly Results Vaidya Sane Ayurved Laboratories Limited has notified the stock exchange that a meeting of its Board of Directors is scheduled for 5th Nov'26. The board will inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 05 Nov 2026, 5:30 am
Vaidya Sane Ayurved Laboratories Schedules Board Meeting for H1 FY27 Results Vaidya Sane Ayurved Laboratories Limited has scheduled a meeting of its Board of Directors on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the half year ended 30th Sep'26, alongside auditor reports. In accordance with SEBI Insider Trading regulations, the trading window for designated persons has been closed from 1st Oct'26 and will reopen 48 hours after the public declaration of the financial results.
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about General Updates
Others (Uncategorized) · 15 Oct 2026, 11:46 pm
Madhavbaug Partners with Parul Institute of Ayurved for Research and Product Development Vaidya Sane Ayurved Laboratories Limited (Madhavbaug) executed an MoU on 9th Oct'26 with Parul Institute of Ayurved, Parul University, to establish a framework for academic collaboration, clinical research, prototype development, training, and knowledge exchange. Key initiatives encompass formulation development, clinical validation, nutraceuticals research, real-world evidence generation, and potential commercialization or licensing. The MoU serves as a collaborative framework without immediate financial commitments, with specific project scopes, IP rights, and commercial terms to be finalized under separate agreements.
Vaidya Sane Ayurved Laboratories Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
Others (Uncategorized) · 13 Oct 2026, 10:58 pm
Vaidya Sane Ayurved Confirms Non-Applicability of Corporate Governance Provisions Vaidya Sane Ayurved Laboratories Limited submitted an undertaking confirming that corporate governance reporting under Regulation 27 of SEBI LODR Regulations, 2015, is not applicable for the quarter ended 30th Sep'26. The company qualifies for an exemption under Regulation 15 as its equity share capital is listed exclusively on NSE's SME platform. A certificate issued by Practicing Company Secretary Deep Shukla & Associates confirms the exemption.
Vaidya Sane Ayurved Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 01 Oct 2026, 10:40 pm
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 30 Sept 2026, 8:56 pm
Reply to Query - Submission of PCS Certificate pursuant to NSE mail on SDD Non-Compliance
Others (Uncategorized) · 22 Sept 2026, 8:52 pm
Vaidya Sane Ayurved Submits SDD Compliance Certificate to NSE In response to NSE's query dated 27th Aug'26 regarding Structured Digital Database (SDD) compliance, Vaidya Sane Ayurved Laboratories Limited submitted a Practicing Company Secretary (PCS) compliance certificate on 21st Sep'26. Issued by M/s. Deep Shukla & Associates under SEBI PIT Regulations, the certificate covers 1st Apr'26 to 20th Sep'26. The auditor confirmed that all 3 required Unpublished Price Sensitive Information (UPSI) events were fully captured in the non-tamperable database with maintained audit trails, verifying zero non-compliance and requiring no remedial actions.
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about General Updates
Others (Uncategorized) · 09 Sept 2026, 9:26 pm
Vaidya Sane Ayurved Laboratories Dispatches 27th AGM Notice and Details E-Voting Vaidya Sane Ayurved Laboratories completed dispatching its 27th AGM notice and FY26 Annual Report on 4th Sep'26, publishing intimations in The Free Press Journal and Navshakti on 9th Sep'26. The AGM will be held virtually on 30th Sep'26 at 1:00 PM IST. Remote e-voting runs from 27th Sep'26 (9:00 AM IST) to 29th Sep'26 (5:00 PM IST), with the cut-off date fixed for 23rd Sep'26. The Register of Members and Share Transfer Books remain closed from 23rd Sep'26 to 30th Sep'26.
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 05 Sept 2026, 6:10 am
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on September 04, 2026.
Outcome · 04 Sept 2026, 9:41 pm
Vaidya Sane Ayurved Approves ESOP Scheme and Leadership Re-Appointments Vaidya Sane Ayurved Laboratories' board approved the VSALL - ESOP 2026 covering 3,00,000 equity shares on 4th Sep'26. The board recommended the 5-year re-appointments of MD Dr. Rohit Madhav Sane, Whole-Time Director Ms. Vidyut Ghag, and three Independent Directors from 30th Sep'26 to 30th Sep'31. It also approved an increase in Dr. Sane's maximum remuneration limit and proposed re-appointing M/s. A.A. Mohare & Co. as Statutory Auditors for five years. The 27th AGM is scheduled for 30th Sep'26, with the voting cut-off on 23rd Sep'26.
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Others (Uncategorized) · 18 Aug 2026, 11:07 pm
Madhavbaug Reports No Deviation in Fund Utilisation from Preferential Issues Vaidya Sane Ayurved (Madhavbaug) reported no deviation or variation in the use of funds raised via preferential issues for the quarter ended 30-Jun'26. The company raised Rs 10.66 cr on 14-Aug'23 and Rs 15.76 cr on 23-Jan'25. Funds were fully utilized for their stated objectives: Rs 59.00 lakh for "Madhavbaug" brand asset payment to Sonu Sood and over Rs 2.34 cr towards constructing hospital premises at Khopoli, with the remainder for general corporate purposes and working capital, aligning with its growth plans.
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 24 Jul 2026, 9:22 pm
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026.
Outcome · 24 Jul 2026, 7:25 pm
Madhavbaug Announces Leadership Change with New CEO Appointment Vaidya Sane Ayurved Laboratories (Madhavbaug) announced a key leadership transition following its board meeting on 24 Jul'26. Mr. Rohit Madhav Sane has resigned as CEO, effective 23 Jul'26, as part of an organisational restructuring but will continue as Managing Director. The board has appointed Mr. D. Ramakrishna as the new CEO and KMP, effective 24 Jul'26. Mr. Ramakrishna brings over 25 years of healthcare and pharmaceutical leadership experience from firms like Apollo Hospitals and Aster DM Healthcare, signaling a strategic focus on growth.
The Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Others (Uncategorized) · 20 Jul 2026, 9:38 pm
Madhavbaug Clarifies and Refiles Financial Results After NSE Query Vaidya Sane Ayurved Laboratories, on 23 Jun'26, clarified discrepancies in its 15 May'26 financial results filing following an NSE query. The company stated that the omission of a balancing figure note was inadvertent and had no financial impact. It also rectified a consolidated XBRL filing where segment details were initially missing due to an error. The revised results have been successfully submitted to the exchange. The company assured it will ensure proper disclosures in future submissions to avoid recurrence of such errors.
Vaidya Sane Ayurved Laboratories Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
Others (Uncategorized) · 16 Jul 2026, 7:26 pm
Madhavbaug Confirms Exemption from Corporate Governance Norms Vaidya Sane Ayurved Laboratories Ltd. (MADHAVBAUG) has confirmed that the Corporate Governance provisions under Regulation 27 of SEBI (LODR) Regulations, 2015, are not applicable for the quarter ended 30-Jun'26. This exemption is due to its exclusive listing on the NSE SME portal, as permitted under Regulation 15(2)(b) of the SEBI LODR. The company submitted a certificate from a Practicing Company Secretary on 16-Jul'26 confirming its status. This significantly reduces the company's compliance and reporting requirements for the period.
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about General Updates
Others (Uncategorized) · 30 Jun 2026, 6:00 pm
Madhavbaug Secures Indian Patent for Herbal Formulation Method Vaidya Sane Ayurved Laboratories has been granted an Indian patent for its "Method of Preparation of Herbal Formulation". The patent (No. 593487), granted on 25 Jun'26, provides intellectual property protection for 20 years from the filing date of 29 Nov'19. Management expects this patent to strengthen its IP portfolio and enhance its competitive position in the Ayurvedic products segment. This grant supports the company's long-term business strategy focused on research and innovation in proprietary Ayurvedic formulations.